Related Experiment Video
Updated: Jun 26, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Severe pertussis in infants: a scoping review
Shuai Guo1,2,3, Yu Zhu1,2,3, Qin Guo1,2,3
1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Severe pertussis (whooping cough) in infants poses significant risks, including fatal complications. Further experimental studies are needed to improve understanding and treatment of this serious respiratory infection caused by Bordetella pertussis.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Pertussis, or whooping cough, is a bacterial respiratory infection caused by Bordetella pertussis.
- Severe pertussis disproportionately affects infants, carrying risks of severe complications and mortality.
- Complications include pulmonary hypertension, heart failure, and encephalitis.
Purpose of the Study:
- To synthesize existing literature on severe pertussis in infants.
- To identify gaps in knowledge and inform future research directions.
Main Methods:
- A scoping review methodology based on Arksey & O'Malley framework.
- Comprehensive searches of PubMed and Embase databases.
- No restrictions on publication language or date.
Main Results:
- 64 articles published between 1979 and 2022 were included from 1299 retrieved.
- 90.6% of included studies were published in the last two decades.
- Studies encompassed epidemiology, pathology, clinical features, risk factors, treatments, and disease burden.
Conclusions:
- Existing literature covers diverse clinical aspects of severe infant pertussis.
- Current studies are primarily observational.
- High-quality evidence requires the initiation of experimental studies.
More Related Videos
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Pneumonia III: Complications and Assessment
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: